Moderna Joining Nasdaq 100 Pushes Vaccine Hopeful to $28 Billion
This article is for subscribers only.
Moderna Inc. has been named the next member of the Nasdaq-100, a tech-heavy index that’s home to some of the biggest outperformers this year, including Tesla Inc. and Zoom Video Communications Inc.
Word of the index inclusion, set to happen before the market opens July 20, added fuel to the vaccine developer’s Monday rally. Moderna climbed as much as 19% to the highest intraday since May 20.